| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907888 | Experimental Hematology | 2005 | 7 Pages |
Abstract
G-PBMC graft content does not influence outcomes after myeloablative AHCT. In particular, no significant association between extensive chronic GVHD was identified with any G-PBMC cell dose, including CD34.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thai M. Cao, Ruby M. Wong, Kevin Sheehan, Ginna G. Laport, Keith E. Stockerl-Goldstein, Laura J. Johnston, Judith A. Shizuru, Robert S. Negrin, Robert Lowsky,